CXCL9 and rheumatoid arthritis: MSC‐124A‐EVs inhibited synovial cell proliferation and migration and promoted synovial cell apoptosis.[126] MiR‐320 and CXCL9 are mutually expressed in synovial tissues from RA patients, and CXCL9 is the target of miR‐320.